- Home
- NCV vs ABSI Comparison
NCV vs ABSI Comparison
Compare NCV & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCV
- ABSI
- Stock Information
- Founded
- NCV 2003
- ABSI 2011
- Country
- NCV United States
- ABSI United States
- Employees
- NCV N/A
- ABSI N/A
- Industry
- NCV Finance Companies
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- NCV Finance
- ABSI Health Care
- Exchange
- NCV Nasdaq
- ABSI Nasdaq
- Market Cap
- NCV 326.2M
- ABSI 318.2M
- IPO Year
- NCV N/A
- ABSI 2021
- Fundamental
- Price
- NCV $3.58
- ABSI $3.22
- Analyst Decision
- NCV
- ABSI Strong Buy
- Analyst Count
- NCV 0
- ABSI 6
- Target Price
- NCV N/A
- ABSI $8.50
- AVG Volume (30 Days)
- NCV 405.1K
- ABSI 5.7M
- Earning Date
- NCV 01-01-0001
- ABSI 11-12-2024
- Dividend Yield
- NCV 12.48%
- ABSI N/A
- EPS Growth
- NCV N/A
- ABSI N/A
- EPS
- NCV N/A
- ABSI N/A
- Revenue
- NCV N/A
- ABSI $4,207,000.00
- Revenue This Year
- NCV N/A
- ABSI $8.57
- Revenue Next Year
- NCV N/A
- ABSI $169.72
- P/E Ratio
- NCV N/A
- ABSI N/A
- Revenue Growth
- NCV N/A
- ABSI N/A
- 52 Week Low
- NCV $2.84
- ABSI $2.45
- 52 Week High
- NCV $3.59
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- NCV 56.07
- ABSI 53.69
- Support Level
- NCV $3.36
- ABSI $2.66
- Resistance Level
- NCV $3.59
- ABSI $2.97
- Average True Range (ATR)
- NCV 0.07
- ABSI 0.35
- MACD
- NCV 0.01
- ABSI 0.02
- Stochastic Oscillator
- NCV 93.62
- ABSI 40.30
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.